We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Maria Farrugia

Maria E. Farrugia MD

Consultant Neurologist, Neurology Department, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, Scotland, United Kingdom

Dr. Maria Farrugia graduated in Medicine and Surgery from the University of Malta in 1995. She moved to the UK in 1997, where she first undertook training in postgraduate medicine, then specialist training in Neurology in Aberdeen Royal Infirmary, Aberdeen, Ninewells Hospital, Dundee, and at the Institute of Neurological Sciences in Glasgow. Dr. Farrugia trained in neuromuscular disorders at the Muscle & Nerve Centre in Oxford (2002-2004) under the supervision of the late Professor John Newsom-Davis and Professor Angela Vincent and Dr David Hilton Jones. Dr. Farrugia graduated in DPhil (University of Oxford) in 2005. Her research work undertaken during the DPhil was based on the clinical (including neurophysiological and radiological) features of MuSK antibody positive myasthenia gravis and laboratory-based characteristics of MuSK antibody positive serum.

Dr. Farrugia took up a Consultant Neurologist post at the Queen Elizabeth University Hospital Glasgow in 2007. She set up the myasthenia gravis service for the West of Scotland in 2007 and has been a lead clinician for myasthenia gravis since 20017 and for adult muscle disorders since 2014.

Dr. Farrugia's research interests include:

  • Various aspects of myasthenia including tools to measure disease burden and fatigue;
  • Myotonic dystrophy;
  • Muscle imaging in neuromuscular disorders;
  • Mitochondrial disorders.